Julie A. Vetalice, Author at ORTHOWORLD

Materialise Gains FDA Clearance for 3D-Printed Pediatric Osteotomy Guides

Materialise received FDA 510(k) clearance to market its Surgicase Orthopaedics system for pre-op planning in pediatric patients undergoing radius and ulna osteotomies.

Mar 16, 2017

Active Implants Secures First Tranche of $40 Million Equity Financing

Investments The Numbers

Active Implants completed the first US $10MM tranche of a $40MM Class D Units financing. Funds will support two ongoing clinical trials of the NUsurface® Meniscus Implant.

Mar 16, 2017

New Knee Arthroscopy Products from DePuy Synthes Mitek Sports Medicine

ORTHOFLASH Sports Medicine

DePuy Synthes Mitek Sports Medicine launched a suite of knee arthroscopy implants and instruments for anterior cruciate ligament and meniscus repair.

Mar 16, 2017

FDA 510(k) Clearance for DJO’s Exprt Revision Hip

Joint Replacement ORTHOFLASH

DJO Global announced FDA 510(k) clearance to market the Exprt® Revision Hip.

Mar 15, 2017

Expanded FDA 510(k) for First Ray Stealth Staple

ORTHOFLASH Trauma

First Ray received FDA 510(k) clearance for additional sizes and materials in the Stealth Staple™ line.

Mar 15, 2017

Arthrosurface to Launch Inlay Glenoid for OVO Primary Stemless Total Shoulder

Joint Replacement ORTHOFLASH

Within 2017, Arthrosurface plans commercial EU launch of an inlay glenoid component for the OVO™ primary stemless total shoulder.

Mar 15, 2017

Soft Tissue Regeneration Raises Series C Financing, Rebrands as Biorez

Investments The Numbers

Soft Tissue Regeneration closed a US $1.5MM Series C Financing and rebranded as Biorez.

Mar 15, 2017

DePuy Synthes Launches ATTUNE Knee Revision Options

Joint Replacement ORTHOFLASH

DePuy Synthes launched the ATTUNE® Revision Fixed Bearing Tibial Base and 14x50mm Cemented Stem.

Mar 15, 2017

Study Results: Rotation Medical Bioinductive Implant in Rotator Cuff Tears

Orthobiologics ORTHOFLASH

Study results indicate that Rotation Medical’s collagen-based Bioinductive Implant induced new tissue formation in all study participants with large and massive rotator cuff tears.

Mar 15, 2017

Study Results: Mesoblast’s Cell Therapy in Degenerative Disc Disease

Orthobiologics ORTHOFLASH

Studies suggest that a single injection of Mesenchymal Precursor Cells resulted in meaningful improvements in chronic low back pain and function that were durable for at least 3 years.

Mar 15, 2017

Get the ORTHOWORLD Newsletter!

Contact Us